Recent Articles

3 Bulletproof Income ETFs for 2017

Analysts are divided on if they think this bull market can last, but agree its a bumpy ride. Smooth it over with these ETF plays More 

Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve

The Big Pharma is set to have a very good 2017 and put 2016 behind it. More 

5 Healthcare Stocks Poised to Trump Q3 Earnings

Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat More 

Eleven Biotherapeutics Inc (EBIO) Soars on Roche Holding Ltd. (ADR) Deal

Eleven Biotherapeutics stock soared on Monday following news of its deal with Roche concerning its Interleukin-6 technology. More 

Johnson & Johnson: My Favorite Dividend King (JNJ)

Johnson & Johnson is one of the strongest dividend payers the market's have to offer. Here's why I'm willing to pay a premium to own JNJ stock More 

How Big Data & Big Pharma Will Transform Drug Development

Big data can be used by big pharma companies like Roche to drastically cut costs, increase drug production and drive long-term stock gains. More 

U.S. Debut of Biosimilar Drugs Threatens Major Biotechs

The introduction of biosimilar drugs will change the biotech landscape ... especially for these three names. More